Petja Lefterova

1.1k total citations
19 papers, 949 citations indexed

About

Petja Lefterova is a scholar working on Immunology, Oncology and Molecular Biology. According to data from OpenAlex, Petja Lefterova has authored 19 papers receiving a total of 949 indexed citations (citations by other indexed papers that have themselves been cited), including 12 papers in Immunology, 9 papers in Oncology and 4 papers in Molecular Biology. Recurrent topics in Petja Lefterova's work include Immune Cell Function and Interaction (11 papers), CAR-T cell therapy research (8 papers) and T-cell and B-cell Immunology (6 papers). Petja Lefterova is often cited by papers focused on Immune Cell Function and Interaction (11 papers), CAR-T cell therapy research (8 papers) and T-cell and B-cell Immunology (6 papers). Petja Lefterova collaborates with scholars based in Germany, United States and Austria. Petja Lefterova's co-authors include Ingo G.H. Schmidt‐Wolf, Robert S. Negrin, D. Huhn, Karl G. Blume, D. Huhn, Bela Mehta, Irving L. Weissman, Lara Fernández, Beate Trojaneck and Sebastian Finke and has published in prestigious journals such as British Journal of Cancer, European Journal of Immunology and British Journal of Haematology.

In The Last Decade

Petja Lefterova

19 papers receiving 923 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Petja Lefterova Germany 11 782 638 149 140 104 19 949
Srinivas S. Somanchi United States 15 1.1k 1.4× 880 1.4× 224 1.5× 195 1.4× 102 1.0× 30 1.3k
Erik Ames United States 15 740 0.9× 488 0.8× 178 1.2× 160 1.1× 38 0.4× 26 965
Chiara Casati Italy 13 579 0.7× 563 0.9× 274 1.8× 40 0.3× 147 1.4× 13 911
Weiqing Jing United States 15 479 0.6× 452 0.7× 225 1.5× 248 1.8× 63 0.6× 29 825
Namiko Okuyama Japan 6 467 0.6× 747 1.2× 285 1.9× 215 1.5× 163 1.6× 9 945
Mobin Karimi United States 11 524 0.7× 414 0.6× 291 2.0× 198 1.4× 71 0.7× 32 927
Kenneth F. May United States 12 899 1.1× 667 1.0× 168 1.1× 36 0.3× 47 0.5× 16 1.1k
Shamaila Munir Ahmad Denmark 18 514 0.7× 422 0.7× 171 1.1× 86 0.6× 39 0.4× 29 790
Jeongheon Yoon United States 14 426 0.5× 274 0.4× 274 1.8× 59 0.4× 124 1.2× 19 776
Massimiliano Petrini Italy 16 356 0.5× 294 0.5× 291 2.0× 57 0.4× 33 0.3× 41 619

Countries citing papers authored by Petja Lefterova

Since Specialization
Citations

This map shows the geographic impact of Petja Lefterova's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Petja Lefterova with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Petja Lefterova more than expected).

Fields of papers citing papers by Petja Lefterova

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Petja Lefterova. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Petja Lefterova. The network helps show where Petja Lefterova may publish in the future.

Co-authorship network of co-authors of Petja Lefterova

This figure shows the co-authorship network connecting the top 25 collaborators of Petja Lefterova. A scholar is included among the top collaborators of Petja Lefterova based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Petja Lefterova. Petja Lefterova is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

19 of 19 papers shown
1.
Lefterova, Petja, et al.. (2000). Induction of Apoptosis in B Lymphoma Cells by Activation with CD40L. Acta Haematologica. 103(3). 168–171. 2 indexed citations
2.
Trojaneck, Beate, Petja Lefterova, D. Huhn, et al.. (2000). COMPARISON OF NON-VIRAL TRANSFECTION METHODS IN MELANOMA CELL PRIMARY CULTURES. Cytokine. 12(6). 828–833. 6 indexed citations
3.
Lefterova, Petja, et al.. (2000). MODULATION OF CELL SURFACE MARKERS ON NK-LIKE T LYMPHOCYTES BY USING IL-2, IL-7 OR IL-12 IN VITRO STIMULATION. Cytokine. 12(9). 1385–1390. 29 indexed citations
4.
Lefterova, Petja, Angela Märten, Peter Buttgereit, et al.. (2000). Targeting of Natural Killer-Like T Immunologic Effector Cells Against Leukemia and Lymphoma Cells by Reverse Antibody-Dependent Cellular Cytotoxicity. Journal of Immunotherapy. 23(3). 304–310. 12 indexed citations
5.
Trojaneck, Beate, Petja Lefterova, Rainer Blasczyk, et al.. (2000). Establishment and Characterization of Colon Carcinoma and Renal Cell Carcinoma Primary Cultures. Cancer Biotherapy and Radiopharmaceuticals. 15(2). 169–174. 6 indexed citations
6.
Scheffold, Christian, Björn Schöttker, Petja Lefterova, et al.. (2000). Increased Sensitivity of Myeloid Leukemia Cell Lines: Potential of Lovastatin as Bone-Marrow-Purging Agent. Acta Haematologica. 104(2-3). 72–79. 5 indexed citations
7.
Schmidt‐Wolf, Ingo, Sebastian Finke, Beate Trojaneck, et al.. (1999). Phase I clinical study applying autologous immunological effector cells transfected with the interleukin-2 gene in patients with metastatic renal cancer, colorectal cancer and lymphoma. British Journal of Cancer. 81(6). 1009–1016. 180 indexed citations
8.
Ebert, Oliver, Angela Märten, Petja Lefterova, et al.. (1999). TNF-alpha secretion and apoptosis of lymphocytes mediated by gene transfer.. PubMed. 5(3). 165–73. 7 indexed citations
9.
Lefterova, Petja, Beate Trojaneck, Oliver Ebert, et al.. (1998). Generation of cytokine-induced killer cells using exogenous interleukin-2, -7 or -12. Cancer Immunology Immunotherapy. 47(4). 221–226. 61 indexed citations
11.
Müller, Markus, et al.. (1998). Potential of Autologous Immunologic Effector Cells for Prediction of Progression of Disease in Patients with Chronic Myelogenous Leukemia. Leukemia & lymphoma. 31(3-4). 335–341. 2 indexed citations
12.
Lefterova, Petja & Ingo G.H. Schmidt‐Wolf. (1997). Coexpression of Lymphoid and Myeloid Markers on Cell Surfaces. Leukemia & lymphoma. 26(1-2). 27–33. 4 indexed citations
13.
Schriever, Folke, et al.. (1997). Human T lymphocytes bind to germinal centers of human tonsils via integrin α4/VCAM‐1 and LFA‐1/ICAM−1 and −2. European Journal of Immunology. 27(1). 35–39. 20 indexed citations
14.
Ebert, Oliver, Sebastian Finke, Marc Herrmann, et al.. (1997). Lymphocyte apoptosis: induction by gene transfer techniques. Gene Therapy. 4(4). 296–302. 49 indexed citations
15.
Schmidt‐Wolf, Ingo G.H., et al.. (1996). Sensitivity of Multidrug-Resistant Tumor Cell Lines to Immunologic Effector Cells. Cellular Immunology. 169(1). 85–90. 82 indexed citations
16.
Schmidt‐Wolf, Ingo G.H., et al.. (1995). Propagation of large numbers of cells of a human mixed‐lineage T‐lymphoid/myeloid. British Journal of Haematology. 90(3). 512–517. 10 indexed citations
17.
Scheffold, Christian, Karim J. Brandt, J R Johnston, et al.. (1995). Potential of autologous immunologic effector cells for bone marrow purging in patients with chronic myeloid leukemia.. PubMed. 15(1). 33–9. 52 indexed citations
18.
Schmidt‐Wolf, Ingo G.H., et al.. (1994). Propagation of large numbers of T cells with natural killer cell markers. British Journal of Haematology. 87(3). 453–458. 102 indexed citations
19.
Schmidt‐Wolf, Ingo G.H., Petja Lefterova, Bela Mehta, et al.. (1993). Phenotypic characterization and identification of effector cells involved in tumor cell recognition of cytokine-induced killer cells.. PubMed. 21(13). 1673–9. 283 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026